Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04036019
Recruitment Status : Unknown
Verified July 2019 by Aibin Liang,MD,Ph.D., Shanghai Tongji Hospital, Tongji University School of Medicine.
Recruitment status was:  Recruiting
First Posted : July 29, 2019
Last Update Posted : July 29, 2019
Sponsor:
Collaborator:
Cellular Biomedicine Group Ltd.
Information provided by (Responsible Party):
Aibin Liang,MD,Ph.D., Shanghai Tongji Hospital, Tongji University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : May 1, 2021
Estimated Study Completion Date : July 30, 2021